Table 2 Actual survival, in days, of... | American Society of Hematology

Table 2

Actual survival, in days, of humanized NOD-SCID mice reconstituted with EBV or EBV and PDCs

NOD-SCID active infection model	Survival, d
NOD-SCID active infection model	1	2	3	4	5	6	7	8
PDC-enriched PBMCs + EBV	41	52	62	71	89	93†	115	164†‡
PBMCs + EBV*	32	41	47	47	54	55	79	82
IFN-α-pulsed PBMCs + EBV*	39	40	42	42	46	53	59	74

NOD-SCID active infection model	Survival, d
NOD-SCID active infection model	1	2	3	4	5	6	7	8
PDC-enriched PBMCs + EBV	41	52	62	71	89	93†	115	164†‡
PBMCs + EBV*	32	41	47	47	54	55	79	82
IFN-α-pulsed PBMCs + EBV*	39	40	42	42	46	53	59	74

n = 8 for each group.

P < .05 compared to PDC-enriched PBMC + EBV group.

No evidence of lymphoma at autopsy.

Mouse was killed.